5-P50-CA58223/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Your saved search

Your RSS Feed

Year	Number of Results
1995	1
2005	1
2010	1
2025	0

Page 1

Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer.

Irvin WJ Jr, Orlowski RZ, Chiu WK, Carey LA, Collichio FA, Bernard PS, Stijleman IJ, Perou C, Ivanova A, Dees EC. Irvin WJ Jr, et al. Clin Breast Cancer. 2010 Dec 1;10(6):465-70. doi: 10.3816/CBC.2010.n.061. Clin Breast Cancer. 2010. PMID: 21147690 Free PMC article. Clinical Trial.

The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.

Conway K, Parrish E, Edmiston SN, Tolbert D, Tse CK, Geradts J, Livasy CA, Singh H, Newman B, Millikan RC. Conway K, et al. Breast Cancer Res. 2005;7(6):R871-80. doi: 10.1186/bcr1315. Epub 2005 Sep 6. Breast Cancer Res. 2005. PMID: 16280033 Free PMC article.

Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.

Klabunde C, Kaluzny A, Ford L. Klabunde C, et al. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):783-9. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 8672997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year